DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients

Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition

(2016) Ching-Wen Lin et al.   Stem Cells International

Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation

(2015) Jun Wan et al.   BMC GENOMICS

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer

(2015) Michelle W. Wong-Brown et al.   BREAST CANCER RESEARCH AND TREATMENT

The role of AGR2 and AGR3 in cancer: Similar but not identical

(2015) Joanna Obacz et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer

(2015) Andrea Mathe et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation

(2015) Hyojin Park et al.   JOURNAL OF CELL BIOLOGY

Mesenchymal Stem Cells Promote Epithelial to Mesenchymal Transition and Metastasis in Gastric Cancer Though Paracrine Cues and Close Physical Contact

(2015) Zengfu Xue et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer

(2015) Andrew Stone et al.   Nature Communications

Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value

(2015) Clare Stirzaker et al.   Nature Communications

TGF-β1-Induced Epithelial–Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells

(2015) Joel Johansson et al.   Frontiers in Oncology

Novel genes associated with lymph node metastasis in triple negative breast cancer

(2015) Andrea Mathe et al.   Scientific Reports

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma

(2015) Aritro Nath et al.   Scientific Reports

Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy

(2015) Zoë Davison et al.   NEOPLASIA

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer

(2014) Kelly A Avery-Kiejda et al.   BMC CANCER

17β-estradiol upregulates GREB1 and accelerates ovarian tumor progressionin vivo

(2014) Laura A. Laviolette et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNAs 206 and 21 Cooperate To Promote RAS-Extracellular Signal-Regulated Kinase Signaling by Suppressing the Translation of RASA1 and SPRED1

(2014) S. B. Sharma et al.   MOLECULAR AND CELLULAR BIOLOGY

A DNA methylation-based definition of biologically distinct breast cancer subtypes

(2014) Olafur A. Stefansson et al.   Molecular Oncology

Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours

(2013) M. Rose et al.   CARCINOGENESIS

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

(2013) Luciano Cascione et al.   PLoS One

The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer

(2013) Attila Marcell Szász et al.   PLoS One

Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy

(2013) Robert Lindner et al.   PLoS One

Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer

(2013) Ming Sun et al.   TUMOR BIOLOGY

Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

(2013) Hisham Mohammed et al.   Cell Reports

DNA methylation based biomarkers: Practical considerations and applications

(2012) Alexandre How Kit et al.   BIOCHIMIE

Regional Activation of the Cancer Genome by Long-Range Epigenetic Remodeling

(2012) Saul A. Bert et al.   CANCER CELL

Triple Negative Breast Cancer: From Molecular Portrait to Therapeutic Intervention

(2012) Pietro Carotenuto et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation

(2012) Pengjun Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Intragenic Enhancers Act as Alternative Promoters

(2012) Monika S. Kowalczyk et al.   MOLECULAR CELL

Reelin Is Involved in Transforming Growth Factor-β1-Induced Cell Migration in Esophageal Carcinoma Cells

(2012) Yi Yuan et al.   PLoS One

Methylation profile of triple-negative breast carcinomas

(2012) M T Branham et al.   Oncogenesis

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

(2011) H-J Kwak et al.   ONCOGENE

Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3 Genes That Are Both Downregulated in Expression in Breast and Prostate Cancers

(2011) Miyako Yamamoto et al.   PLoS One

Epigenetic modifications and human disease

(2010) Anna Portela et al.   NATURE BIOTECHNOLOGY

Histone modifications at human enhancers reflect global cell-type-specific gene expression

(2009) Nathaniel D. Heintzman et al.   NATURE

Epigenetics and human disease

(2008) Martin Hirst et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY